Category Archives: LABD-25-01

Real Estate … Dead at Resistance

January 17, 2025 By in $SPSIBI, Biotech, DRV, DRV-25-01, IYR, LABD, LABD-25-01, Real Estate, SPBIO, Spring-to-Up-Thrust, Wyckoff, XBI 1 Comment

Repeating Set-Up

Real estate (IYR) has pushed higher above resistance and stopped dead; currently trading in a very narrow range.

It wouldn’t be all that interesting if price action was not in a repeating set-up:

Wyckoff Spring-to-Up-Thrust

Click on the side bar under the same name to see all posts related to this set-up.

Note: A set-up does not guarantee anything.

It’s just a market observed phenomenon that may result in a directional move (not advice, not a recommendation).

Real Estate IYR, Daily

There it is:

This is what’s called The Danger Point®

The risk of being wrong on a short position is at its least (not advice, not a recommendation).

Positioning (updates)

Biotech XBI is spending a lot of time hovering around support and not progressing downward (no matter all the Fibonacci correlations).

With that, LABD-25-01 was closed at slightly above break even (not advice, not a recommendation).

Real estate IYR was entered short early in the session via leveraged inverse DRV, as trade DRV-25-01. Stop for the trade is currently the session low. (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Economic ‘Implosion’

January 15, 2025 By in $SPSIBI, Biotech, Great Depression 2.0, LABD, LABD-25-01, SPBIO, Uneducated Economist, Wyckoff, XBI, ZeroHedge Tags: , , , , 1 Comment

Collapsing On Several Fronts

‘Retail’, selling silver, link here.

Jewelry whacked, link here.

Loan Shark, link here.

You know it’s bad when booze takes a hit, link here and here.

Producer prices launch higher, link here.

Lumber prices collapse, again, link here.

Travel restrictions, link here.

Then, there are ‘valuations’, link here.

Also then, there’s this, link here.

Lastly, short squeezes and liquidity traps … bear market behavior, link here.

Speaking of ‘short squeeze’, we had biotech do just that in the pre-market (and regular) session.

Biotech XBI, Daily

If it really is/was a short squeeze, once shorts are covered, the expectation is for price to continue lower (not advice, not a recommendation).

Included in the chart, is a bit of insight you’re not likely to find anywhere else.

Note the distance of each retrace after a leg down. Less each time and Fibonacci multiples.

As stated yesterday, XBI posted outside down. That means price action penetrated the lows of the prior session and closed lower.

As wild as it may seem, penetrating the lows and closing lower, put XBI in Wyckoff ‘spring’ position.

That’s what we saw with today’s action.

As this post is being created (11:45 a.m., EST), XBI action continues to erode to the downside currently trading at the 87.60 – area.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Downside Leader … Biotech

January 14, 2025 By in $SPSIBI, Biotech, IBB, IWM, LABD-25-01, Russell 2000, SPBIO, TZA, TZA-25-01, Wyckoff, XBI, ZeroHedge Tags: , , , , 1 Comment

Confirming, Right-Side Channel

It’s a recurring theme with biotech.

Over and again, this sector (IBB, XBI) is not participating in tandem with the other major indices.

Today’s pre-market mayhem higher over supposed slower outlays of possible trade tariffs to happen some-time, some-day, caused the major indices to launch upward. 🙂

Well, everybody seemed to be blasting higher except one sector, biotech.

Wyckoff Directed Action

No matter what the ‘narrative’ may be, Wyckoff analysis directs us to look at what the market is actually doing, then interpret the action.

Early after the open, trade TZA-25-01, was exited, +8.9% gain, short position opened in biotech via LABD, Trade: LABD-25-01 (not advice, not a recommendation).

Biotech XBI, Daily

Today posted outside down, taking out both the high and low of the prior session.

Note the trading channel and width, Fibonacci 13-Days.

Also note the two ‘breakaway gaps’. The second one on January 10th, much wider than November 12th, last year.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279